Diabetic Retinopathy study: AI-BRIDGE vs Educational Materials
Official title Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes
ClinicalTrials.gov ID: NCT06763952
What this study is testing
- What it's testing
- The study wants to see if using AI to screen for diabetic eye disease and help schedule follow‑up visits works better than usual care.
- Who it's for
- It is looking for adults who have diabetes and visit one of eight primary‑care clinics.
- What's involved
- Participants will have their eye images taken during a regular clinic visit. The AI will analyze the images, give education, and if needed help arrange an eye‑doctor appointment. No extra tests beyond the usual care are added.
- Time commitment
- The study lasts as long as the participant stays in the clinic program, with routine visits and occasional eye‑care appointments as needed.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 and older
You may be able to join if
- Clinics
- Clinic must be from a health system with at least two clinics that meet eligibility criteria and will agree to join.
- Number of unique patients with diabetes should be \>550 over any continuous 15-month period prior to the clinic providing a letter of support to...
- No point-of-care screening system in use for DR.
- Have an electronic health record to track patient data and agree to share limited data set as requested.
You likely can't join if
- Have a documented DR screening in the electronic health record within 12 months of the date of the primary care visit
- Contraindication includes diagnosed with macular edema, severe non-proliferative retinopathy, proliferative retinopathy, radiation retinopathy, or...
- Pregnant
See the full eligibility criteria
- Clinics
- Clinic must be from a health system with at least two clinics that meet eligibility criteria and will agree to join.
- Number of unique patients with diabetes should be \>550 over any continuous 15-month period prior to the clinic providing a letter of support to participate in the trial.
- No point-of-care screening system in use for DR.
- Have an electronic health record to track patient data and agree to share limited data set as requested.
- Have a member of the clinical team who can commit to serving as the clinic champion for this study.
- Have the IT infrastructure to deploy an artificial-intelligence-based eye camera in the clinic. Patient
- Diagnosis of type 1 or 2 diabetes
- No known diabetic retinopathy
- No diabetic retinopathy screening in the past 12 months Patient
- Have a documented DR screening in the electronic health record within 12 months of the date of the primary care visit
- Contraindication includes diagnosed with macular edema, severe non-proliferative retinopathy, proliferative retinopathy, radiation retinopathy, or retinal vein occlusion
- Pregnant
The study team makes the final eligibility decision.
Where it is enrolling
- Madison, Wisconsin, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 22 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Madison, Wisconsin, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.